TWI368525B - Nanoparticles as paracellular drug delivery system - Google Patents

Nanoparticles as paracellular drug delivery system

Info

Publication number
TWI368525B
TWI368525B TW094145234A TW94145234A TWI368525B TW I368525 B TWI368525 B TW I368525B TW 094145234 A TW094145234 A TW 094145234A TW 94145234 A TW94145234 A TW 94145234A TW I368525 B TWI368525 B TW I368525B
Authority
TW
Taiwan
Prior art keywords
nanoparticles
delivery system
drug delivery
paracellular drug
paracellular
Prior art date
Application number
TW094145234A
Other languages
Chinese (zh)
Other versions
TW200638952A (en
Inventor
Hsing Wen Sung
Hosheng Tu
Original Assignee
Nanomega Medical Corp Usa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/029,082 external-priority patent/US7265090B2/en
Application filed by Nanomega Medical Corp Usa filed Critical Nanomega Medical Corp Usa
Publication of TW200638952A publication Critical patent/TW200638952A/en
Application granted granted Critical
Publication of TWI368525B publication Critical patent/TWI368525B/en

Links

TW094145234A 2005-01-04 2005-12-20 Nanoparticles as paracellular drug delivery system TWI368525B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/029,082 US7265090B2 (en) 2004-10-05 2005-01-04 Nanoparticles for paracellular drug delivery

Publications (2)

Publication Number Publication Date
TW200638952A TW200638952A (en) 2006-11-16
TWI368525B true TWI368525B (en) 2012-07-21

Family

ID=55856053

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094145234A TWI368525B (en) 2005-01-04 2005-12-20 Nanoparticles as paracellular drug delivery system

Country Status (1)

Country Link
TW (1) TWI368525B (en)

Also Published As

Publication number Publication date
TW200638952A (en) 2006-11-16

Similar Documents

Publication Publication Date Title
EP1901796A4 (en) Drug delivery system
GB2442875B (en) Regulated drug delivery system
ZA201002014B (en) Drug delivery system
IL198911A0 (en) Drug delivery
IL184824A0 (en) Infusion delivery system
IL227899A0 (en) Vortex feature for drug delivery system
HK1122508A1 (en) Nanoparticles for protein drug delivery
EP1848749A4 (en) Contact drug delivery system
ZA201101737B (en) Progestin-containing drug delivery system
ZA200709490B (en) Breath actuated drug delivery system
EP1858483A4 (en) Delivery system for multiple drugs
EP2035488A4 (en) Micelles for drug delivery
EP2010162A4 (en) Drug delivery composition
IL190245A0 (en) Iontophoretic drug delivery system
ZA200903317B (en) Helically-shaped drug delivery system
EP2023900A4 (en) Controlled dose drug delivery system
IL212357A0 (en) Sustained drug delivery system
EP1858493A4 (en) Oral drug delivery system
GB0606415D0 (en) Topical drug delivery
EP2226083A4 (en) Drug delivery system
GB0515363D0 (en) Drug delivery system
TWI368525B (en) Nanoparticles as paracellular drug delivery system
GB0401008D0 (en) Drug delivery system
TWI340043B (en) Oral drug delivery system
GB0620334D0 (en) Regulated drug delivery system

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees